Novartis AG NVS
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.79% | 9.88% | |||
| Total Other Revenue | -6.63% | 32.12% | |||
| Total Revenue | 0.52% | 10.55% | |||
| Cost of Revenue | -2.85% | 6.98% | |||
| Gross Profit | 1.62% | 11.77% | |||
| SG&A Expenses | -4.74% | 3.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 96.85% | 202.38% | |||
| Total Operating Expenses | 1.06% | 3.97% | |||
| Operating Income | -0.50% | 25.57% | |||
| Income Before Tax | -69.15% | 11.20% | |||
| Income Tax Expenses | -88.04% | 48.17% | |||
| Earnings from Continuing Operations | -63.28% | 3.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -14.29% | -- | |||
| Net Income | -63.17% | 3.42% | |||
| EBIT | -0.50% | 25.57% | |||
| EBITDA | 1.32% | 20.26% | |||
| EPS Basic | -63.00% | 3.64% | |||
| Normalized Basic EPS | -0.96% | 25.71% | |||
| EPS Diluted | -63.16% | 3.64% | |||
| Normalized Diluted EPS | -0.96% | 25.59% | |||
| Average Basic Shares Outstanding | -0.47% | -0.21% | |||
| Average Diluted Shares Outstanding | -0.47% | -0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -0.55% | |||